Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases
OwnerRichard Graham Knowles, Peter Ward +1inventors
InventorsRichard Graham Knowles, Peter Ward, Anthony Terence Nials
Life of this patent
Estimating the term…
Abstract
This invention relates to treating pulmonary diseases such as chronic obstructive pulmonary disease or asthma by administering a phosphodiesterase 4 inhibitor in combination with an H1-receptor antagonist.
Claims10
A method of prophylaxis, treating, or reducing the duration or frequency of the exacerbations associated with a respiratory disease comprising administering to a patient in need thereof an effective amount of a PDE 4 inhibitor and an H1-receptor antagonist.
A composition for the prophylaxis of, treating, or reducing the exacerbations associated with, a pulmonary disease comprising an effective amount of a PDE4 inhibitor, an effective amount of an H1-receptor antagonist and a pharmaceutically acceptable excipient.
Use of an effective amount of a PDE4 inhibitor and an effective amount of an H1-receptor antagonist in the manufacture of a medicament for the prophylaxis, treatment or reduction in duration or frequency of the exacerbations associated with a respiratory disease.
Use of an effective amount of a PDE4 inhibitor and an effective amount of an H1-receptor antagonist in the prophylaxis, treatment or reduction in duration or frequency of the exacerbations associated with a respiratory disease.
Dependencies are inferred from the claim text.